Eton Pharmaceuticals Inc. (ETON) Misses Q2 EPS by 14c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q2 EPS of ($0.06), $0.14 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $7.4 million versus the consensus estimate of $9.5 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c